Reshoring and Nearshoring: Rebuilding Pharma Supply Chains for Localization and Resilience

For decades, the global pharmaceutical industry operated on a model of maximum efficiency, often driven by the pursuit of the lowest cost. This led to a highly complex, geographically dispersed pharma supply chain, with raw material suppliers, API (Active Pharmaceutical Ingredient) manufacturers, and drug packagers often located thousands of miles...